Sleep apnea and snoring affect one and three people. If not addressed, obstructed sleep apnea can lead to serious health issues including diabetes, heart attack, hypertension, and glaucoma. Most therapy to address sleep apnea has been centered around invasive CPAP machines. Signifier Medical Technologies is a med-tech startup focused on non-invasive solutions for sleep-disordered breathing conditions. In February, the company received FDA approval for eXciteOSA, a medical device that provides neuromuscular stimulation to the tongue to address the conditions causing sleep apnea. Unlike other treatments, the device is used during the day and not while the patient is sleeping, resulting in increased comfort and convenience. 2- minute treatments have been shown to drastically improve the quality of sleep and reduce obstructive sleep apnea and snoring. There is a connected app for the device that encourages patient adherence and also provides valuable data to clinicians. London TechWatch caught up with CFO Alastair Maxwell to learn more about the company’s groundbreaking treatment, strategic plans, and latest round of funding from investors that include Alan Howard, Segulah Medical Acceleration, Pioneer Healthcare Partners, and Angelus Partners.